Morgan Stanley’s CVS Health CVS Stock Holding History

Morgan Stanley’s Portfolio CVS Stock Details CVS Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.19B	Sell	17,316,165 -617,464	-3%	-$42.6M	0.08%	226
2025 Q1	$1.22B	Buy	17,933,629 +375,565	+2%	+$25.4M	0.09%	209
2024 Q4	$788M	Sell	17,558,064 -4,690,278	-21%	-$211M	0.06%	318
2024 Q3	$1.4B	Sell	22,248,342 -612,209	-3%	-$38.5M	0.1%	179
2024 Q2	$1.35B	Sell	22,860,551 -6,179,441	-21%	-$365M	0.1%	178
2024 Q1	$2.32B	Sell	29,039,992 -32,190,578	-53%	-$2.57B	0.19%	97
2023 Q4	$4.83B	Buy	61,230,570 +30,115,866	+97%	+$2.38B	0.21%	85
2023 Q3	$2.17B	Sell	31,114,704 -2,138,720	-6%	-$149M	0.22%	82
2023 Q2	$2.3B	Buy	33,253,424 +1,982,929	+6%	+$137M	0.23%	81
2023 Q1	$2.32B	Sell	31,270,495 -2,305,893	-7%	-$171M	0.25%	71
2022 Q4	$3.13B	Buy	33,576,388 +3,311,928	+11%	+$309M	0.36%	52
2022 Q3	$2.89B	Buy	30,264,460 +885,605	+3%	+$84.5M	0.39%	43
2022 Q2	$2.72B	Buy	29,378,855 +6,613,041	+29%	+$613M	0.35%	54
2022 Q1	$2.3B	Sell	22,765,814 -1,515,236	-6%	-$153M	0.31%	68
2021 Q4	$2.5B	Buy	24,281,050 +1,431,615	+6%	+$148M	0.31%	70
2021 Q3	$1.94B	Buy	22,849,435 +712,077	+3%	+$60.4M	0.26%	90
2021 Q2	$1.85B	Sell	22,137,358 -2,388,184	-10%	-$199M	0.24%	98
2021 Q1	$1.85B	Buy	24,525,542 +590,266	+2%	+$44.4M	0.27%	82
2020 Q4	$1.63B	Sell	23,935,276 -751,994	-3%	-$51.4M	0.25%	90
2020 Q3	$1.44B	Buy	24,687,270 +1,627,516	+7%	+$95M	0.28%	85
2020 Q2	$1.5B	Buy	23,059,754 +2,413,910	+12%	+$157M	0.33%	69
2020 Q1	$1.22B	Buy	20,645,844 +3,352,364	+19%	+$199M	0.33%	73
2019 Q4	$1.28B	Buy	17,293,480 +2,523,691	+17%	+$187M	0.3%	75
2019 Q3	$932M	Buy	14,769,789 +1,004,154	+7%	+$63.3M	0.25%	94
2019 Q2	$750M	Buy	13,765,635 +1,560,142	+13%	+$85M	0.2%	111
2019 Q1	$658M	Buy	12,205,493 +2,075,326	+20%	+$112M	0.19%	121
2018 Q4	$664M	Buy	10,130,167 +1,111,929	+12%	+$72.9M	0.2%	113
2018 Q3	$710M	Buy	9,018,238 +659,975	+8%	+$52M	0.18%	121
2018 Q2	$538M	Buy	8,358,263 +1,848,678	+28%	+$119M	0.15%	141
2018 Q1	$405M	Buy	6,509,585 +525,080	+9%	+$32.7M	0.11%	184
2017 Q4	$434M	Sell	5,984,505 -2,287,011	-28%	-$166M	0.12%	178
2017 Q3	$673M	Buy	8,271,516 +268,854	+3%	+$21.9M	0.2%	110
2017 Q2	$644M	Buy	8,002,662 +332,375	+4%	+$26.7M	0.19%	115
2017 Q1	$602M	Buy	7,670,287 +816,012	+12%	+$64.1M	0.19%	119
2016 Q4	$541M	Sell	6,854,275 -5,861,599	-46%	-$463M	0.18%	122
2016 Q3	$1.13B	Sell	12,715,874 -815,542	-6%	-$72.6M	0.39%	36
2016 Q2	$1.3B	Buy	13,531,416 +972,726	+8%	+$93.1M	0.47%	25
2016 Q1	$1.3B	Buy	12,558,690 +1,072,934	+9%	+$111M	0.5%	20
2015 Q4	$1.12B	Buy	11,485,756 +1,304,751	+13%	+$128M	0.41%	33
2015 Q3	$982M	Buy	10,181,005 +885,607	+10%	+$85.4M	0.36%	41
2015 Q2	$975M	Sell	9,295,398 -329,527	-3%	-$34.6M	0.34%	47
2015 Q1	$993M	Buy	9,624,925 +355,159	+4%	+$36.7M	0.37%	43
2014 Q4	$893M	Buy	9,269,766 +1,427,771	+18%	+$138M	0.33%	48
2014 Q3	$624M	Buy	7,841,995 +117,140	+2%	+$9.32M	0.24%	87
2014 Q2	$582M	Buy	7,724,855 +948,573	+14%	+$71.5M	0.23%	83
2014 Q1	$507M	Buy	6,776,282 +333,827	+5%	+$25M	0.21%	96
2013 Q4	$461M	Sell	6,442,455 -410,834	-6%	-$29.4M	0.2%	114
2013 Q3	$389M	Buy	6,853,289 +970,675	+17%	+$55.1M	0.18%	122
2013 Q2	$336M	Buy	+5,882,614	New	+$336M	0.17%	144